[A case of chronic hepatitis C developing drug induced intrahepatic cholestasis due to anti-inflammatory drug during interferon therapy].
Niiya
M
M
Department of General Internal Medicine, Jikei University School of Medicine, Kashiwa Hospital, Japan.
Suzuki
K
K
Naito
Y
Y
Konuma
Y
Y
Fujise
K
K
Watanabe
R
R
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced*; D002908:Chronic Disease; D004008:Diclofenac / Q000009:adverse effects*; D006526:Hepatitis C / Q000150:complications* / Q000628:therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D013488:Suppositories
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013488:Suppositories; D004008:Diclofenac